**Vascular Graft Solutions** (VGS) aims to revolutionize coronary and peripheral bypass surgeries, arterial reconstruction, and arteriovenous fistula repair. Founded in **2009** and headquartered in **Israel**, the company focuses on developing and commercializing innovative solutions to enhance bypass surgery outcomes. Its flagship product, the **VEST (Venous External Scaffolding Technology)**, serves as an external mechanical support for autologous vein grafts, effectively improving vein graft longevity by optimizing hemodynamics and mitigating vein graft disease. Notably, randomized controlled trials and real-world data studies in Europe have confirmed the significant biomechanical impact of external stenting, resulting in improved clinical outcomes. In **June 2018**, Vascular Graft Solutions secured a **Series B investment** led by **Champel Capital**, indicating confidence in the company's pioneering approach to vascular healthcare.
No recent news or press coverage available for Vascular Graft Solutions.